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Due to low ion permeability of lipid bilayers, it has been and still is common practice to use transporter 
molecules such as ionophores or lipophilic chelators to increase trans-membrane diffusion rates and 
loading efficiencies of radionuclides into liposomes. Here, we report a novel and very simple method for 
loading the positron emitter 64Cu2+ into liposomes, which is important for in vivo positron emission 
tomography (PET) imaging. By this approach, copper is added to liposomes entrapping a chelator, which 
causes spontaneous diffusion of copper across the lipid bilayer where it is trapped. Using this method, we 
achieve highly efficient 64Cu2+ loading, high radionuclide retention, and favorable loading kinetics, 
excluding use of transporter molecule additives. We investigate the molecular coordination of entrapped 
copper using X-ray absorption spectroscopy, and demonstrate high adaptability of the loading method to 
different lipid formulations. We demonstrate high in vivo stability of 64Cu-liposomes in a canine cancer 
model and evaluate tumor accumulation in mice using PET imaging. With this work, it is demonstrated 
that copper ions are capable of crossing a lipid membrane unassisted. This method is highly valuable for 





1. Introduction  
In recent years, the use of imaging in cancer diagnostics and treatment planning has increased 
considerably. New companion diagnostic agents are emerging1,2 that can be used to select patients that 
will be responsive to a specific treatment. Methods for radiolabeling of nanodrugs are particularly 
interesting as nanomedicines provide new possibilities in companion diagnostics and personalized 
medicine. A number of radiolabeling methods have already been developed for preparing radioactive 
liposomes,3-13 where the main focus has been on single-photon emission computed tomography (SPECT) 
isotopes. Labeling of liposomes with PET isotopes can provide high-resolution and superior quantitative 
information on the pharmacokinetics and biodistribution of potential nanodrugs, which can be of high 
value during drug development and for clinical translation.1,2 Among the different methods for preparing 
radioactive liposomes, remote loading of radionuclides into the aqueous core of liposomes seems to 
provide the greatest in vivo stability. The radionuclides reside in a protected environment inside the 
liposome, which reduce the risk of transmetalation after administration, in comparison to radionuclide 
surface chelation.5,6 In addition, no liposomal surface alterations are imposed when loading radionuclides 
into the aqueous core in contrast to surface chelation. This is often important when investigating the in 
vivo behaviour of liposomal formulations with specific physical-chemical surface properties.   
 During the last 30 years, ionophores and lipophilic chelators have been used for remote loading of 
radionuclides such as 111In3+, 67/68Ga3+, 64Cu2+, 123/124I-, 177Lu3+ and 99mTcO4- into liposomes.7-12 So far, only a 
few ionophore assisted loading (IAL) procedures have been developed for liposomal PET imaging 
applications.1,12,13 Despite the generally high loading efficiencies, high radionuclide retention, rapid 
loading kinetics and successful in vivo liposomal performance there are disadvantages of using transporter 
molecules such as ionophores or lipophilic chelators (hereafter referred to as ionophores as a common 
term) for remote loading of radionuclides into liposomes. One drawback to consider is the penalty in 
Gibbs free energy, which derives from stripping the radionuclide from the ionophore upon transfer to the 




Figure 1. Loading of Cu2+ into liposomes. After addition of Cu2+ to a liposome solution, Cu2+ can pass the 
lipid bilayer either unassisted (left) or assisted (right) by an ionophore such as 2-hydroxyquinoline (2HQ). 
Cu2+ then forms a complex with the encapsulated chelator (DOTA) and is hereby trapped inside the 
liposome. 
 
This effect reduces the thermodynamic driving force for forming the radionuclide-chelator complex inside 
the liposome and thereby potentially the loading efficiency. Thus, choosing a correctly matched entrapped 
chelator and ionophore with respect to copper affinity, is essential for obtaining a thermodynamic stable 
encapsulation of the radionuclide12 when using the IAL method. Otherwise, the radionuclide may be 
prematurely released after in vivo administration, which can result in erroneous estimation of the 
distribution of the liposomes and lowering of PET image quality. Furthermore, ionophores can be toxic to 
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humans as a consequence of their high lipophilicity and ability to disrupt ionic gradients of cells leading 
to disturbances in physiological functions.14 Hence, ionophores used for loading of liposomes with 
radionuclides has to be removed by purification after preparation, which is not ideal for PET isotopes due 
to their short half-life (e.g. 64Cu has 12.7 h half-life).  
 Several research groups have investigated the membrane permeability of anions and cations.15-18 
From these studies, low ion permeability of phospholipid bilayers, such as liposomes, is expected to result 
in highly unfavorable loading kinetics of charged ion species. Common practice is therefore to use 
ionophores to increase the trans-membrane ion diffusion rate, and thereby improve the loading kinetics of 
charged ions such as radionuclides into liposomes.7-13 Despite previous knowledge and findings within 
this field, the present work describes a novel loading method of the PET radionuclide 64Cu2+ into 
liposomes, excluding the use of ionophores (an unassisted loading). In this method, 64Cu2+ (or copper) is 
added to preformed liposomes entrapping a high affinity copper chelator (Figure 1, left). The aqueous 
core of these liposomes is depleted from free copper due to presence of the entrapped chelator. This 
establishes a strong trans-membrane copper gradient, which facilitate diffusion of copper ions across the 
lipid bilayer. Once inside, the encapsulated chelator traps copper. The fact that ionophores can be avoided 
in the current unassisted loading (UAL) method, presents a major advancement with respect to 
radionuclide entrapment stability and simplicity of loading compared to other and our previous published 
methods.12 It is furthermore highly surprising due to the general belief that cation diffusion across lipid 
bilayers is very slow. 
 In the present work, the loading efficiency of the new UAL method is compared to our previously 
published method, which relies on the use of 2-hydroxyquinoline (2HQ) for ionophore assisted transport 
of Cu2+.12 In order to characterize and optimize the conditions at which the loading is most favorable, the 
loading efficiency and loading kinetics, of the UAL method, is investigated as function of temperature. 
The UAL method is furthermore tested for several liposome formulations, including ligand-targeted, 
pegylated, non-pegylated, gel or fluid like, cholesterol rich or cholesterol depleted, cationic, anionic and 
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zwitterionic lipid compositions. The loading of 64Cu2+ is analyzed using size exclusion chromatography 
(SEC) and radio thin layer chromatography (radio-TLC).  
 The UAL method is investigated further by analysis of liposomes loaded with non-radioactive 
copper. The loading efficiency of these liposomes is analyzed by ICP-MS and ligands coordinating the 
liposome-entrapped copper are explored by X-ray absorption spectroscopy.  
 The in vivo performance of 64Cu-loaded liposomes is evaluated in tumor-bearing mice and in a 
canine cancer model. Biodistribution and tumor accumulation is quantified using combined 
PET/computed tomography (CT) imaging. 
 
2.  Materials and Methods  
2.1. Materials 
1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-stearoyl-3-trimethylammonium-propane 
(DSTAP), hydrogenated soy phosphatidylcholine (HSPC), 1,2-distearoyl-sn-glycero-3-phosphocholine 
(DSPC), cholesterol (CHOL), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy 
(polyethylene glycol)-2000] (DSPE-PEG2000) and  1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy (polyethylene glycol)-5000]-Folate (DSPE-PEG5000-Folate) were purchased from Avanti Polar 
Lipids (Alabama, USA). The freeze-dried lipid mixture (stealth formulation): HSPC:CHOL:DSPE-
PEG2000 in the molar ratio (56.5:38.2:5.3) was purchased from Lipoid® GmbH (Ludwigshafen, Germany). 
DSPE-PEG2000-RGD was synthesized in our own lab. 1,4,7,10-tetra-azacyclododecane-1,4,7,10-
tetraacetic acid (DOTA) was purchased from Macrocyclics (Dallas, USA). The buffer 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) and all other solvents and chemicals were 
purchased from Sigma Aldrich (Schnelldorf, Germany) and were used without further purification. 
7 	
Amicon Ultra-15 centrifugal filter units were purchased from Millipore (Denmark). TLC-plates Silica gel 
60 F254 were purchased from Merck (Darmstadt, Germany). Mini-extruder was purchased from Avanti 
Polar Lipids (Alabama, USA). LIPEX Thermobarrel Pressure Extruder (10 mL) was purchased from 
Northern Lipids (Burnaby, Canada) and the Minimate™ tangential flow filtration system was purchased 
from Pall Corporation (Canada). Human serum was purchased from Sigma Aldrich (Schnelldorf, 
Germany). Mice and dog blood was taped from animals into Hirudine tubes, and the plasma fraction was 
collected. 
 
2.2. 64Cu production 
Copper-64 was produced on a PETtrace cyclotron (GE Healthcare). The production of 64Cu2+ was carried 
out via the 64Ni(p,n)64Cu nuclear reaction as described previously.12 A specific activity of 3.3 TBq/µmol 
(Cu) was achieved on average corresponding to 36% radioactive Cu nuclides (64Cu/Cu). The 64CuCl2 was 
isolated by evaporation of aqueous 1 M HCl to dryness once added to a vial and used hereafter for remote 
loading of liposomes. 
 
2.3. Preparation of liposomes 
Chelator-containing liposomes were prepared as follow. The lipids were mixed in a chloroform:methanol 
(9:1) mixture  and dried to a lipid-film under a gentle stream of nitrogen. Organic solvent residues were 
removed under reduced pressure overnight. As an exception, the HSPC:CHOL:DSPE-PEG2000 
(56.5:38.2:5.3) lipid formulation (stealth formulation) was prepared directly from the freeze-dried 
powder. The lipid-film or the powder was dispersed by adding a hydration buffer (10 mM HEPES, 150 
mM NaCl) containing the chelator, DOTA (10 mM). Hydration buffers were adjusted to either pH 4.0 or 
7.4 using NaOH and/or HCl resulting in an osmolarity of 330-380 mOsm/kg. Lipid suspensions were 
prepared at 50-65 mM and hydrated at 65°C for 60 min. Multi-lamellar vesicles (MLVs) were sized to 
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large unilamellar vesicles (LUVs) by multiple extrusions through 100 nm polycarbonate filters using an 
Avanti mini-extruder or a LIPEX Thermobarrel Pressure Extruder (at 10-15 bar nitrogen).  
 Un-encapsulated DOTA was removed by repeated buffer exchange using Amicon Ultra-15 
centrifugal filter units (100 kDa cutoff) exchanging the external buffer with a HEPES buffer (10 mM, 150 
mM NaCl, pH 7.4, 295 mOsm/kg). In brief, 0.5 mL liposomes (50 mM) were diluted to a total volume of 
12 mL using HEPES buffer, and 11 mL were spun through the filter. The spin filtration was repeated four 
times, and the purified liposomes were collected. It is important to note, that repeated filtration is crucial 
for achieving high loading efficiency (>95%) and fast loading kinetics, since the presence of chelating 
components on the liposome exterior lowers the copper transmembrane gradient, which slows down the 
loading kinetics and reduces the overall loading efficiency. The HSPC:CHOL:DSPE-PEG2000 
(56.5:38.2:5.3) liposome formulation was as an exception purified using a Minimate™ tangential flow 
filtration system.   
 Empty liposomes were prepared as follow. The lipid-film or powder was dispersed in aqueous 
buffer (10 mM HEPES, 150 mM NaCl, pH 7.4, 295 mOsm/kg). The lipid suspension was hydrated at 
65°C for 60 min. MLVs were sized to LUVs by multiple extrusions through 100 nm polycarbonate filters 
using an Avanti mini-extruder or a LIPEX Thermobarrel Pressure Extruder (at 10-15 bar nitrogen).  
 All liposome preparations were analyzed on size and zeta-potential using a Zeta Potential 
analyzer (ZetaPALS, Brookhaven, SE). 
 
2.5 Unassisted loading (UAL) of 64Cu into liposomes 
Purified chelator-containing liposomes (0.5-5.0 mL, 5-50 mM, internal pH 7.4) were added to a capped 
vial containing radioactive 64CuCl2 (50-1500 MBq) in either dry or solvated form (in HEPES buffer). The 
sample was constantly stirred in a thermostatted lead-container during incubation. Unassisted loading 
9 	
(UAL) was conducted by sample incubation for 60-75 min at 25-55°C. Formulations used for in vivo 
experiments were loaded at 55°C for 75 min.   
 
2.6. Ionophore assisted loading (IAL) of 64Cu2+ into liposomes  
In experiments using the ionophore 2-hydroxyquinoline (2HQ) for ionophore assisted loading (IAL) of 
64Cu2+ into chelator-containing liposomes, 10 µL 2HQ in MilliQ water (C2HQ = 0.314 mM) were added to 
the vial containing radioactive 64Cu2+ prior to addition of chelator-containing liposomes as previously 
reported.12 Subsequently, purified chelator-containing liposomes (internal pH 4.0) were added, and 
loading proceeded as described for the UAL method. 
 
2.7. 64Cu2+ loading efficiency measured by size exclusion chromatography (SEC) 
64Cu2+ loading efficiency was measured using size exclusion chromatography (SEC). The fraction of un-
entrapped 64Cu-DOTA, in the 64Cu-liposome solution, was quantified by separating 64Cu-DOTA from 
64Cu-liposomes using a Sephadex G-25 column (1 x 25 cm) eluted with a HEPES buffer (10 mM, 150 
mM NaCl, pH 7.4) with an injection volume of 500 µL and a flow rate of 4 mL/min. The 64Cu-liposomal 
fraction was collected between 20-70 min and the 64Cu-DOTA or 64Cu(2HQ)2 fraction between 70-100 
min. An inline radioactivity detector was used for monitoring the SEC elution profile. The radioactivity in 
the liposomal fraction (Alip) as well as the total sample activity (Atot,SEC) was measured in a dose calibrator 
(Veenstra VDC-505). The loading efficiency was calculated as the ratio of the decay-corrected liposomal 
fraction and total sample activity, %loadSEC = 2Alipexp(Δt / T1/2) / Atot,SEC, where Δt~70-80 min is the time 
difference between the measurement of Alip and Atot, and T1/2 = 12.7 h is the half-life of 64Cu. 
 The loading efficiency of DSPC:CHOL:DSPE-PEG2000 (55:40:10) liposomes entrapping DOTA 
was investigated using SEC. The loading experiment was conducted at 30, 40 and 50°C using the new 
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UAL method and our previously reported IAL method.12 Empty liposomes composed of 
DSPC:CHOL:DSPE-PEG2000 (55:40:10) were included as control in this study. 
 
2.8. 64Cu2+ loading efficiency and kinetics measured by thin layer chromatography (radio-TLC) 
Free 64Cu2+ binds to the Sephadex column and hence cannot be quantified by SEC. The fraction of free 
64Cu2+ in the 64Cu-liposome solution was therefore quantified by separation of 64Cu-DOTA and 64Cu2+ by 
radio-TLC. Briefly, 2 µL sample was spotted on a TLC plate (Silica gel 60 F254) and 10% aqueous 
ammonium acetate:methanol (50:50) was used as eluent. The retention factor (Rf) of 64Cu-DOTA was 0.3-
0.4, while 64Cu2+ remains at the origin (Rf = 0). The TLC plate was read by a radio-TLC scanner 
(MiniGita Star GM, Raytest) or a Phosphor-imager (Cyclone Plus, Perkin Elmer). The radioactive peaks 
were integrated using associated computer software. The loading efficiency was calculated as %𝑙𝑜𝑎𝑑!"# = 𝐴!"!!"#$/𝐴!"!,!"# , where ACu-DOTA is the 64Cu-DOTA TLC peak activity and Atot,TLC is the 
total 64Cu2+ radioactivity deposited on the TLC plate. Since the 64Cu-liposomes collapse once dried on the 
TLC silica gel, the 64Cu-DOTA TLC-peak corresponds to the total radioactivity associated with DOTA in 
the sample (including encapsulated and un-encapsulated 64Cu-DOTA if present).  
 The loading kinetics of HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3) liposomes were investigated 
using TLC at 25, 40 and 55°C. First, 64CuCl2 was dissolved in buffer (10 mM HEPES, 150 mM NaCl, pH 
7.4) at 200 MBq/mL. Secondly, 100 µL 9.4 mM liposomes were equilibrated at the target temperature 
(25, 40 or 55°C) in an acid washed HPLC vial with constant stirring. The experiments were initiated by 
adding 100 µL 64Cu2+ solution (equilibrated at the target temperature) and TLC spots were deposited after 





2.9. X-ray absorption spectroscopy of non-radioactive Cu-loaded liposomes 
Liposomes were prepared from HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3), by hydration of lipid 
powder in a solution of 10 mM HEPES and 100 mM DOTA (pH 7.4, 325 mOsm/kg). These liposomes 
were prepared with a higher copper loading capacity using 100 mM DOTA, and were extruded and 
purified as described in section 2.3.  
 The liposomes were loaded with non-radioative copper (Cu) by mixing with CuCl2 dissolved in 
aqueous buffer (10 HEPES mM, 150 mM NaCl, pH 7.4). First, 400 µL liposomes (entrapping 100 mM 
DOTA) were mixed with 66 µL of a CuCl2 solution (6.2 mM). Secondly, the liposome-copper mixture 
was incubated in a closed vial at 55°C for 2 h, and the sample was shaken gently regularly. Finally, the 
sample was equilibrated at room temperature. 
 The loading efficiency was measured by ICP-MS (Thermo Scientific, iCAP Q). This was 
accomplished by mixing 10 µL Cu-loaded liposome sample with 40 µL EDTA (1 mM) (dissolved in 
HEPES buffer, pH adjusted to 7.4) and 950 µL HEPES buffer. The sample was incubated at room 
temperature for 15 min, and the total Cu content of the EDTA spiked sample was determined by a 100-
fold dilution of the sample in 3% HNO3 solution (spiked with 25 ppb Ga as internal standard). The Cu 
content of the liposome exterior was determined via spin filtration of the EDTA spiked sample. Briefly, 
950 µL EDTA spiked sample were transferred to an Amicon Ultra-15 centrifugal filter unit (100 kDa 
cutoff), which was spun at 1000 g for 15 min, or until 250 µL had passed the filter. Following, filtrate was 
diluted 100 fold with 3% HNO3 solution (spiked with 25 ppb Ga as internal standard). The copper content 
of the unfiltered sample and sample filtrate were quantified by ICP-MS, and the loading efficiency was 
calculated as the ratio of filtrate and total copper content. The recovery of copper for the spin filtration 
method was tested by conducting loading experiments with either no or empty liposomes not entrapping 
any chelator using matching conditions as for loading of the DOTA-liposomes.  
 Copper K-edge X-ray absorption spectra were recorded for solvated Cu (790 µM CuCl2 in 10 
mM HEPES, 150 mM NaCl, pH 7.4), Cu-DOTA (790 µM CuCl2, 1.0 mM DOTA in 10 mM HEPES, 150 
12 	
mM NaCl, pH 7.4), and Cu-loaded liposomes (720 µM CuCl2) on beamline I811 at the MAX-II 
synchrotron at MAXIV Laboratory, Lund, Sweden,19 using a Si(111) double-crystal monochromator. The 
samples were mounted in 1 mm thick sample holders20 and cooled to 20 K in a liquid helium cryostat. 
Fluorescence data were collected using a Vortex silicon-drift detector (50 mm2) in the XANES region 
8830-9180 eV. Five to ten scans of 25 min were recorded for each sample in following intervals: Pre-
edge data (150-20 eV before the edge) were collected in steps of 5 eV for 1 sec, the edge (from 20 eV 
before to 30 eV above the edge) in steps of 0.3 eV for 1 sec, the XANES region (30-120 eV above the 
edge) in steps of 1 eV for 1 sec, and the NEXAFS region (120-200 eV above the edge) in steps of 5 eV 
for 3 sec. Comparing successive scans, no photo reduction or radiation damage of the samples were 
observed.  
 The scans were, averaged, background subtracted, normalized and energy calibrated using 
WinXAS.21 Full multiple scattering calculations of XANES spectra by finite-difference methods (FDM) 
were performed using FDMNES,22 on clusters with a radius of 4.5 Å of the Cu-atom. The fit between 
calculated and experimental spectra was evaluated with an R factor given as: 
𝑅!"#$% = !!"# ! !!!"# !!!"#(!)          (1) 
where µ is the absorption/fluorescence yield from normalized XANES spectra as function of energy, E. 
 
2.10. Animal xenograft model 
Human FaDu head and neck cancer cells (5 x 106 cells in 100 µL media and matrigel) were inoculated 
subcutaneously in the flanks of female NMRI nude mice (n = 5) and were allowed to grow 14 days 
(tumor sizes < 0.5 g). All nude mice were purchased from Taconic (Borup, Denmark), and all 
experimental procedures were conducted with the guidelines set forth by the Danish Ministry of Justice. 
64Cu-liposome suspensions were intravenously injected (i.v.) for PET imaging. All animals were 
anesthetized with sevofluran and catheterized to ensure proper tail vein injection. The average 
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administered lipid dose level of 64Cu-liposomes was 20 mg/kg. The approximate activity dose level was 
12 MBq/animal. PET data were acquired on a MicroPET® Focus 120 (Siemens Medical Solutions, 
Malvern, PA, USA). The voxel size was 0.866 x 0.866 x 0.796 mm3 and in the centre field of view the 
resolution was 1.4 mm full width at half maximum (FWHM). PET scans were acquired 5 min after 
injection of radiolabeled liposomes (scan time 5 min) and again 24 h after injection (scan time 15 min). 
Data were reconstructed with the maximum a posterior (MAP) reconstruction algorithm. For anatomical 
localization of activity, CT images were acquired with a MicroCAT® II system (Siemens Medical 
solutions, Malvern, PA, USA). 
 After data reconstruction, PET- and CT images were fused using the Inveon Software (Siemens). 
The emission scans were corrected for random counts and dead time. The PET- and CT images were used 
to identify regions of tracer uptake and to generate regions of interest (ROIs) that were applied to each 
scan separately. The blood activity was estimated from a spherical ROI constructed within the left heart 
ventricle. This ROI was subsequently segmented into a blood activity ROI consisting only of voxels 
displaying minimum 80% of maximum voxel activity of the original ROI. Liposomal activity within each 
organ was determined from ROIs placed within the border of the investigated organs. ROIs were placed 
to ensure sufficient organ coverage without compromising the influence of partial volume effects or 
respiratory movements. The liposomal accumulation in the different organs was expressed as percentage 
of injected dose per gram (%ID/g) as well as standardized uptake value (SUV).23 The organ density was 
assumed to be 1 g/cm3 for all tissues and tumors.  
 
2.11. Biodistribution and circulation properties in a clinical canine model 
A large breed dog (Great Dane, male, 48 kg) underwent 64Cu-liposome PET/CT scanning following a 
previous surgical removal of a neuroblastoma to evaluate presence of metastatic or residual cancerous 
tissue. The study was approved by the Ethical Committee at Dept. Small Animal Clinical Sciences at 
University of Copenhagen in Denmark. The dog was injected with 2 mg/kg of dexamethasone disodium 
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phosphate approx. 2 h prior to infusion of 64Cu-liposomes to minimize risks of immunologic reactions. 
64Cu-liposomes were infused over a 20-min period at increasing infusion rates, a total of 402.7 MBq of 
64Cu-liposomes was infused, equalling a mean lipid concentration of 4.3 mg/kg. EDTA stabilized blood 
samples were collected at multiple time points during a 24-hour period. Blood samples were weighed and 
well-counted in triplicates and specific decay corrected injected activity was determined from an expected 
blood volume (8% of bodyweight).  
 After a distribution period of 24-hours the dog was anesthetized and a whole body PET/CT scan 
performed to evaluate biodistribution of the 64Cu-liposomes and presence of detectable metastatic or 
residual disease. PET/CT scans were performed using a combined PET/CT scanner (Biograph 40 
PET/CT) consisting of a high resolution PET scanner (21.6 cm axial field) and a 40-row multi-slice CT 
scanner. Images were reconstructed using a 3D acquisition mode and attenuation corrected using the 
concurrent CT scan. PET images were acquired using 2.5 min per bed positions and reconstructed using 
TrueX® (Siemens, Erlangen, Germany) 3D reconstruction (21 iterations, 3 subsets), and smoothed using a 
Gaussian filter having a FWHM of 2 mm in all directions, and a matrix size of 336×336. 
 Image analysis of attenuation corrected and reconstructed PET/CT images were performed using 
commercial software (Pmod, Pmod Technologies, Switzerland). The acquired images revealed no signs of 
residual or metastatic cancerous tissue. 64Cu-liposome activity in the blood, liver, spleen and muscle 24 h 
after 64Cu-liposome infusion were evaluated by constructing reference ROIs using the methodology 
described above and reported as %ID/g. All regions were drawn well within the margins of tissues and 
organs, and excluding regions containing larger blood vessels, e.g. the hilar region of the liver, to avoid 
artefacts and minimize partial volume effects and respiratory movement. 
 
2.12. In vitro stability of 64Cu-liposomes in serum 
15 	
In vitro stability of 64Cu-liposomes, prepared by the UAL method, was tested in human serum, canine and 
mice plasma. Liposomes loaded with 500 MBq 64Cu/mL were mixed with serum or plasma in a 1:1 ratio, 
and incubated for 18 h at 37°C. The liposome-serum/plasma mixture (200 µL) was separated on a size-
exclusion column (Sephadex G50 fine, 25 x 1.5 cm, flow rate 1 mL/min) and fractions were collected 
every 2nd min. The 64Cu activity of the different fractions was measured using a calibrated high-purity 
germanium detector (Princeton, Gammatech). Each sample was placed in a distance of 20 cm measured 
from the surface of the detector crystal. Energy and efficiency calibrations were performed prior to 
measuring using certified sealed radioactive sources of 133Ba and 152Eu. The spectra were obtained and 
analyzed using Canberra Genie2K software. The 64Cu activity of each sample was determined by 
integration of the 511 keV annihilation peak and the activities were calculated based on the 20 cm 
efficiency calibration. 64Cu-DOTA was included as a control to determine retention-time (fraction range) 
of the liposome encapsulated and free 64Cu-DOTA. The leakage of 64Cu-DOTA from the liposomes in 
serum or plasma was calculated as leakage =  𝐴!"#$!!"!!!" / 𝐴!"#$!!"!!! , where 𝐴!"#$!  is the activity of the 
i’th fraction (see supplementary Figure S1). 
 
3. Results  
3.1. Loading of 64Cu2+ evaluated by SEC 
In the present work, loading of 64Cu2+ into DSPC:CHOL:DSPE-PEG2000 (50:40:10) liposomes was tested 
using an UAL and an IAL method, which are schematically illustrated in Figure 1. The two loading 
methods are compared by the overall loading efficiency (%loadsec) determined using SEC (Figure 2A), 
which for IAL using 2HQ (Figure 2B) shows an increase from 83% to 92% (11% relative increase) in 
response to raising the temperature from 30°C to 50°C. In contrast, the UAL method (without 2HQ) 
shows an increase from 47% to 97% (>100% relative increase) in response to raising the temperature 
from 30°C to 50°C (Figure 2B).  
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Figure 2. Evaluation of 64Cu2+ loading into DOTA-liposomes using size exclusion chromatomography 
(SEC). (A) A typical SEC elution profile of 64Cu2+ remote loaded liposomes (B) Loading efficiency 
presented as a function of temperature for the unassisted (UAL) and ionophore assisted (IAL) remote 
loading. The liposomes were composed of DSPC:CHOL:DSPE-PEG2000 in the molar ratio (50:40:10) with 
the chelator (DOTA) entrapped. The error bars represent SEM (n = 3). 
 
The largest difference in loading efficiency, between the two loading methods, is observed at 30°C and 
40°C. Furthermore, 2HQ is observed to reduce the maximal achieved loading from 97% ± 1% to 92% ± 
1%. As control, loading of empty liposomes (without DOTA encapsulated) was carried out using the 
method described above and showed loading efficiencies of 1% ± 1% and 5% ± 1% for 5 mM and 50 mM 
DSPC:CHOL:DSPE-PEG2000 (50:40:10) lipid formulations, respectively, when incubated for 1 h at 55°C.  
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3.2. Loading kinetics of 64Cu2+ evaluated by radio-TLC 
The kinetics of loading 64Cu2+ into liposomes, utilizing the new UAL method, was evaluated using radio-
TLC (Figure 3A). Loading experiments were conducted at 25, 40 and 55°C, using HSPC:CHOL:DSPE-
PEG2000 (56.5:38.2:5.3) liposomes (Figure 3B).  
 
Figure 3. Loading efficiency of liposomes given as function of time for the UAL method. The loading 
efficiency, for loading of 64Cu2+ into liposomes, is evaluated at 25, 40 and 55°C by the use of radio-TLC. 
(A) TLC elution profile as function of time (1, 3, 8, 15, 30 and 60 min). The corresponding TLC plate is 
shown as an insert in panel A. (B) Degree of loading 64Cu2+ into liposomes (%loadTLC). The liposomes 
were composed of HSPC:CHOL:DSPE-PEG2000 in the molar ratio (56.5:38.2:5.3). The error bars 




Slow loading kinetics is observed at room temperature (25°C), where a maximal loading efficiency of 
36% ± 4% is reached after 60 min. At 40°C, loading kinetics is faster, and a maximal loading efficiency 
of 88% ± 1% is reached after 60 min. The fastest loading is observed at 55°C, where 97% ± 1% loading is 
reached after 60 min. The initial velocity of the 64Cu2+ loading reaction, judged by the degree of loading 
achieved after 1 min, increases from 5% ± 1% at 25°C to 12% ± 1% at 40°C, and reaches 38% ± 3% at 
55°C. A temperature increase of 30°C thus results in a 8-fold increase in initial loading rate. 
 
3.3 Remote loading of non-radioactive Cu and X-ray absorption spectroscopy analysis 
The coordination chemistry of copper was investigated using X-ray absorption spectroscopy (XAS) in 
order to elucidate copper species present in HEPES buffer, HEPES buffer containing DOTA and in 
remote loaded liposomes prepared using the UAL method. Therefore, HSPC:CHOL:DSPE-PEG2000 
(56.5:38.2:5.3) liposomes, entrapping 100 mM DOTA, was mixed with non-radioactive copper (Cu). 
Sample incubation was conducted at 55°C for an extended period of time (2 h) to facilitate loading of the 
larger amount of copper, compared to loading of 64Cu2+. The liposome sample was examined using ICP-
MS, which resulted in a total copper content of 720 µM and an encapsulation efficiency of 93%. Loading 
of HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3) liposomes, entrapping no chelator, resulted in 5% loading. 
The recovery of copper from the spin filters has furthermore been analyzed by conducting a test loading 
without any liposomes. This test shows that upon complex formation of copper and EDTA, more than 
96% of the copper in the sample is recovered in the filtrate. Solutions containing 720 µM copper (in 
HEPES buffer) or 720 µM copper and 1.0 mM DOTA (in HEPES buffer) was prepared. Together, these 
solutions and a sample of Cu-loaded liposomes were investigated using XAS.  
X-ray absorption spectroscopy: The experimental and calculated XANES spectra of solvated Cu in 
HEPES buffer, Cu-DOTA and Cu-loaded liposomes are shown in Figure 4A. The XANES spectra 
confirm the presence of copper in oxidation state +2 (Cu2+) in all samples as seen by the absence of the 
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characteristic pre-edge feature around 8983 eV occurring in the XANES spectra of copper in oxidation 
state +1.24  
 
Figure 4. Experimental (solid line) and calculated (dashed) XANES spectra (panel A). From top: (i) 
Solvated Cu2+ fitted with a five-coordinate water complex, (ii) solvated Cu2+ fitted with clinoatacaite, (iii) 
Cu-DOTA fitted with Cu-DOTA complex, and (iv) copper loaded liposome fitted with a linear 
combination of experimental spectra of Cu-DOTA and solvated Cu2+. (B–D) The atomic models used in 
the calculations of XANES spectra including distances to atoms in the first coordination shell. Panel B 
show [Cu(H2O)5]2+ used to model the solvated Cu2+ in HEPES. (C) The most abundant Cu coordination in 
clinoatacamite, which was also used to model the solvated Cu2+ in HEPES. The [Cu(OH)4Cl]4– complex is 
shown with the nearest neighbour copper atoms. (D) Cu-DOTA complex. Colour code: copper (brown), 
chlorine (green), oxygen (red), nitrogen (blue), carbon (black) and hydrogen (white). 
 
 XANES spectra were calculated from different models in order to identify the 63Cu2+-species 
present in the HEPES buffer sample. Firstly, XANES spectra were calculated for different complexes in 
which Cu2+ is solely ligated by water in the following geometries: i) Jahn-Teller distorted six-coordinate 
[Cu(H2O)6]2+, ii) regular five-coordinate square pyramidal [Cu(H2O)5]2+ and iii) elongated five-coordinate 
square pyramidal [Cu(H2O)5]2+ in which the four equatorial ligands were D2d-distorted from the mean 
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equatorial plane as shown in Figure 4B. This latter model shown in Figure 4B was adapted from the XAS 
solution structure of [Cu(H2O)5]2+ at room temperature by Frank et al.,25 and results in a significantly 
better agreement with the measured XANES spectrum (Rxanes = 0.0217), as compared to the six-coordinate 
complex (Rxanes = 0.0384) and the regular five-coordinate square pyramidal complex (Rxanes = 0.0284). A 
1.0% reduction of the Cu–O distances due to temperature differences further improved the fit as shown in 
Figure 4A (Rxanes = 0.0179).  
 After a few days, a precipitate was observed in the buffer sample. An X-ray powder diffraction 
analysis identified this precipitate as clinoatacamite, which is a monoclinic polymorph of dicopper 
trihydroxide chloride.26 Clinoatacamite contains three crystallographically different copper atoms, of 
which three quarters of them adopt a six-coordinate Jahn-Teller distorted geometry [Cu(OH)4Cl2]4–, 
similar to that shown in Figure 4C, which is a strong indication of coordination of chloride to copper. A 
XANES spectrum was therefore calculated from this structure. This resulted in a very good agreement 
with the measured XANES spectrum, as some of the spectral features are better explained by this model 
compared to the Cu-aqua models. This includes improved fit of the subtle edge feature at 8990 eV as well 
as the shoulder around 9013 eV (Figure 4A). As the crystal structure was solved at room temperature 
shorter coordination distances were observed in the experimental XANES spectrum, and therefore an 
isotropic contraction of the unit cell of 2.0% was applied to optimize the fit (Rxanes = 0.0145). The 
orthorhombic crystal structure of the Cu-DOTA,27 which is shown in Figure 4D was used to calculate the 
XANES spectrum of the Cu-DOTA complex. The fit was further improved by a 1.9% isotropic 
contraction of the unit cell in which Rxanes improved from 0.0214 to 0.0149. 
 A linear combination of the experimental spectra of solvated Cu2+ and Cu-DOTA, was fitted to 
the experimental XANES spectrum of Cu-loaded liposome (Rxanes = 0.0064). The fit is shown in Figure 
4A. The fraction of copper coordinated to DOTA was refined to 88%, which is in agreement with the 
loading of 93%. This concludes that Cu2+ is loaded into the liposomes, where it is chelated by DOTA. 
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3.4 Dependence on lipid composition and activity 
The new UAL method was tested for an extended set of liposome formulations listed in Table 1 and all 
were successfully loaded (%loadSEC >95%, %loadTLC >95%). The loading efficiency, evaluated by SEC 
and radio-TLC, is found to be independent of: 1) DSPE-PEG2000 content for the stealth formulation, 2) 
targeting groups such as DSPE-PEG2000-RGD and DSPE-PEG5000-Folate, 3) presence of cationic and 
anionic lipids, 4) cholesterol content and 5) lipid saturation or membrane phase-state (gel or fluid). 
Moreover, stealth liposomes were successfully loaded at low, medium and high radioactivity levels (10-
800 MBq/mL 64Cu2+). 
 
Table 1. Liposomal formulations and loading conditions for which successful unassisted loading (UAL) 
of 64Cu2+ has been achieved (%loadSEC > 95%, %loadTLC > 95%). Loading conditions are specified as: 
loading temperature, lipid concentration and 64Cu activity. 
 
Liposomal formulations (molar ratio) Loading conditions 
Stealth liposomes  
HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3) 55°C, 3.3-10 mM, 10-800 MBq/mL 
DSPC:CHOL:DSPE-PEG2000 (50:40:10) 55°C, 3.3-10 mM, 50-100 MBq/mL 
Targeted stealth liposomes 





55°C, 3.3 mM, 50-200 MBq/mL 
Cationic and anionic liposomes  
HSPC:CHOL:DSTAP:DSPE-PEG2000 (43.5:38:12.5:6) 55°C, 3.3 mM, 50-200 MBq/mL 
HSPC:CHOL:DSTAP:DSPE-PEG2000 (31:38:25:6) 55°C, 3.3 mM, 50-200 MBq/mL 
POPC:POPG:CHOL:DSPE-PEG2000 (35:40:20:5) 55°C, 5 mM, 50-200 MBq/mL 
DPPC:DPPG:DSPE-PEG2000 (55:40:5) 55°C, 5 mM, 50-200 MBq/mL 
Zwitterionic liposomes 
POPC (100) 40, 55°C, 5 mM, 50-200 MBq/mL 
POPC:CHOL (60:40) 55°C, 5 mM, 50-200 MBq/mL 
DPPC (100) 55°C, 3.3 mM, 50-200 MBq/mL 





3.5 In vivo and in vitro performance of 64Cu-liposomes 
The in vivo performance of 64Cu2+ loaded HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3) liposomes 
(prepared by the UAL method) was investigated in a xenograft FaDu tumor model. Each animal was 
injected in the tail vein with 200 µL liposome formulation (3.3 mM lipid, 60 MBq/mL) corresponding to 
20 mg lipid/kg and an activity dose level of 12 MBq/animal. The mice were PET/CT scanned 10 min and 
24 h post injection, as shown in the PET/CT fusion images of Figure 5A-D.  
 
Figure 5. Coronal PET/CT image of FaDu tumor xenografts mice models injected with 64Cu-liposomes 
(prepared using the UAL method). (A-B) Organ and tumor distribution 10 min post injection of 64Cu-
liposomes and (C-D) 24 h post injection. The intensity scale bar presents the uptake in %ID/g and covers 
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the range 0–28 %ID/g in (A-B) and 0–11 %ID/g in (C-D). The liposomes were composed of 
HSPC:CHOL:DSPE-PEG2000 in the molar ratio (56.5:38.2:5.3). The dashed circle in (B,D) defines the 
position of the tumor. 
 
The blood, tumor and organ accumulation, compiled in Table 2, has been quantified using PET imaging. 
Ten minutes post injection, the 64Cu-liposomes reside in the blood pool, which is evident in Figure 5A 
where a high 64Cu2+ radioactivity is observed in the region of the heart. Only little activity is observed in 
the tumor (Figure 5B) at this time point. After 24 h, the 64Cu-liposomes accumulate in the spleen, liver 
and tumor as indicated by high 64Cu2+ radioactivity in tissues in Figure 5C and uptake data in Table 2. The 
64Cu-liposome content in the blood decreases from (33 ± 4) %ID/g at 10 min to (6.4 ± 0.4) %ID/g at 24 h, 
which corresponds to a half-life of T1/2 = 9.7 h assuming mono-exponential blood clearance. Assuming an 
average weight of 27.5 g and an average blood volume of 8% v/w, 73% of the injected dose is accounted 
for by the blood pool 10 min post injection.  
 
Table 2. Biodistribution data for 64Cu-liposomes administered to FaDu tumor bearing mice (n = 5) and a 
dog (n = 1). The liposomes were composed of HSPC:CHOL:DSPE-PEG2000 in the molar ratio 
(56.5:38.2:5.3). Scans were performed 10 min or 24 h post injection. Values are means ± SEM (n = 5). 
 
 Mice Dog 
Organs %ID/g SUV %ID/kg SUV 
Blood (10 min) 33 ± 4 10 ± 1 - - 
Blood (24 h) 6.4 ± 0.4 1.9 ± 0.1 12.0 5.7 
Liver (24 h) 13 ± 1 3.9 ± 0.3 7.9 3.8 
Spleen (24 h) 14 ± 2 4.2 ± 0.6 5.2 2.5 
Muscle (24 h) 0.4 ± 0.1 0.12 ± 0.03 0.4 0.2 
Tumor (24 h) 6 ± 2 1.8 ± 0.6 - - 
 
64Cu-liposomes, prepared by the UAL method, were administered to a single canine cancer model, which 
in concordance with evaluation of disease status also provided information on the in vivo stability in a 
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large animal model. PET/CT fusion images of the canine cancer model are shown in Figure 6 A-B, where 
the activity is located primarily in the region of the spleen, liver and heart.  
 
Figure 6. PET/CT image of a canine cancer model injected with 64Cu-liposomes (prepared using the UAL 
method) 24 h post injection. (A,B) Sagittal and coronal plane PET/CT images are shown with white 
arrows indicating position of spleen, liver and heart. (C) The blood clearance profile is plotted as function 
of time post injection of 64Cu-liposomes. The dashed line represents the fit of a mono-exponential 
function. The error bars represent SEM (n = 3). The liposomes were composed of HSPC:CHOL:DSPE-
PEG2000 in the molar ratio (56.5:38.2:5.3). 
 
SUVs and %ID/kg were quantified by PET imaging and results are reported for tissues and blood in Table 
2. The blood clearance profile, shown in Figure 6C, has been fitted using a mono-exponential function, 
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which yields a half-life of T1/2 = 24 h ± 4 h. The mono-exponential fit (Figure 6C) shows that the blood 
pool accounts for more than 75% of the injected dose at the time of injection.    
Additionally, the in vitro stability of 64Cu-liposomes, prepared by the UAL method, was investigated in 
human serum, canine and mice plasma (incubated for 18 h and at 37°C) and was found to be very high 
with <5%, <3% and <2% leakage of 64Cu-DOTA, in three separate experiments.  
 
 4. Discussion  
We have previously presented an efficient method for remote loading of 64Cu2+ into liposomes using the 
ionophore 2HQ.12 In this approach, copper is coordinated by 2HQ outside the liposomes, which lowers 
the kinetic energy barrier of crossing the lipid bilayer, and hence facilitates diffusion of the copper 
complex (Figure 1). Once inside the liposome, 2HQ is exchanged by entrapped chelators due to the 
copper affinity and excess chelator concentration. In the current study, a new method, excluding the use 
2HQ or any other ionophore, is presented. In this UAL method, copper is added to liposomes entrapping a 
chelator, and contrary to previous knowledge, copper spontaneously diffuses across the lipid bilayer 
where it is captured by the high affinity chelator (DOTA).   
 The new UAL method has major advantages compared to previous reported IAL methods,4,7-12 
because of its simplicity, excluding the use of any ionophore. The UAL method only requires an 
encapsulated chelator and proper incubation temperature to obtain high loading efficiencies (>95%) of 
radioactive 64Cu2+ into liposomes. High loading efficiency (%loadSEC > 95%, %loadTLC > 95%) is obtained 
for a range of 64Cu2+ activity levels, lipid concentrations and composition (Table 1) thus highlighting the 
robustness and flexibility of the new loading method. In particular, loading efficiency is found not to 
depend on the presence of pegylated lipids, targeting ligands, liposome surface charge, or lipid phase state 
(gel or fluid). However, changes in surface potential/charge of liposomes are known to affect the spatial 
distribution of ions near the lipid membrane,28,29 which could affect the loading efficiency of Cu2+. Yet, no 
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change in loading efficiency is observed for cationic HSPC:CHOL:DSTAP:DSPE-PEG2000 (31:38:25:6) 
or anionic POPC:POPG:CHOL:DSPE-PEG2000 (35:40:20:5) liposomes (Table 1) indicating that the 
membrane translocating copper specie might be neutral. In work by Powel et al., speciation of copper in 
saline solution, in the presence of atmospheric CO2 pressure, revealed CuCO3(aq) to be the predominant 
form of copper at pH 7.4.30 Oil/water-partitioning studies of copper, conducted by Blust and coworkers,31 
furthermore showed a dramatic increase in oil/water-partitioning of copper as pH was raised from 6.5 to 
7.0. The latter result has been attributed to the formation of carbonate compounds by copper speciation. 
Both observations made by Powel and Blust fit our suggestion that copper is able to translocate the lipid 
bilayer in a charge independent manner. Our XANES analyses do not support the hypothesis of CuCO3 
being the dominant species in HEPES buffer. We see that copper is present either as a distorted five-
coordinate square pyramidal [Cu(H2O)5]2+ complex  (Figure 4B) or adopt a coordination to chloride 
(Cu(OH)4Cl2) (Figure 4C) similar to that found in clinoatacamite. This difference might be explained by 
the larger concentration of copper and chloride used in the XAS experiment compared the concentration 
used in the speciation calculation.30 Liposome formulations with melting transition temperature below 
55°C have furthermore been successfully loaded at 55°C. This indicates that little or no DOTA is leached 
from the liposome as a consequence of crossing the gel-fluid transition temperature.   
 The loading efficiency of the new UAL and the 2HQ IAL method is compared using SEC. The 
methods are compared at 30, 40 and 50°C, which reveals a large difference in the temperature response of 
the loading efficiency (Figure 2). For the IAL method, the loading efficiency is found to be weakly 
dependent on temperature, where as a larger response to changes in temperature is observed for the UAL 
method. This difference reflects a significant change in activation energy, and hence a change in loading 
mechanism; an effect that might be attributed to altered transmembrane diffusion rate of the translocating 
copper specie in the presence of 2HQ. An important observation is the lower loading efficiency obtained 
at 50°C for the IAL method compared to the UAL method. Hence, the presence of 2HQ results in a free 
energy penalty of stripping copper from the ionophore, which shifts the loading reaction: Cu2+ 
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(unloaded/free) ⇔ Cu2+ (loaded into liposome), towards the unloaded form. This argument is fully 
supported by the ligand exchange constant for the exchange of Cu2+ between 2HQ and DOTA determined 
in our recent work.12 
 In order to find the optimal loading conditions and elucidate the temperature response of the UAL 
method, loading kinetics has been investigated by radio-TLC. The loading rate (slope of %loadTLC) and 
efficiency are found to be highly dependent on temperature, and 8-fold increase in initial loading rate is 
observed in response changing the temperature from 25°C to 55°C (Figure 3B). This change in initial rate 
correlates to the observed change in loading efficiency shown in Figure 2B, and reflects the increased 
energy barrier for copper to cross the lipid bilayer unassisted. Despite the reduction in loading rate at 
room temperature, the loading still progresses and reached 36% after 1 h. At 55°C incubation, 92% 
loading is obtained within 15 min, and >97% loading is achieved within 60 min; hence 55°C was chosen 
as the optimal loading temperature. Furthermore, the obtained loading (%loadTLC) evaluated at 60 min 
(Figure 3B) correlates with the loading efficiency obtained by SEC (%loadSEC) shown in Figure 2B. 
Loading of 64Cu2+ into empty liposomes resulted in highly reduced (or nearly negligible) loading 
efficiencies for both the IAL and UAL method when compared to liposomes entrapping DOTA. The 
loading efficiency of empty liposomes furthermore scaled with the lipid concentration, and agrees with 
the expected entrapped volume of 100 nm liposomes.  
 The UAL method has been investigated by XAS to identify copper species, which are likely to be 
involved in the loading process. Liposomes with a high DOTA content have been prepared and loaded 
with 720 µM Cu2+, which show that even large amount of copper, can be loaded into liposomes using the 
UAL method. Analysis of XANES spectra (Figure 4A) confirms copper to be present in oxidation state 
+2 and to be coordinated to DOTA as expected upon loading into liposomes. In a HEPES buffer 
containing DOTA (1 mM) copper is concluded to be coordinated to DOTA (Figure 4D). A linear 
combination of the experimental spectra of solvated Cu2+ and Cu-DOTA, has been fitted to the 
experimental XANES spectrum of copper loaded liposome (Rxanes = 0.0064, fit is shown in Figure 4A). 
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From this fit, the fraction of copper coordinated to DOTA is refined to 88%, which is in agreement with 
the loading efficiency of 93% obtained by ICP-MS. This concludes that Cu2+ is loaded into the liposomes, 
where it is chelated by DOTA. 
 The in vivo performance of liposomes loaded with 64Cu2+ using the UAL method has been 
accessed in small and large animal models. 64Cu-liposomes was administered to mice bearing head and 
neck cancer xenografts, and accumulation in tissues of interest has been determined 10 min and 24 h post 
injection (Figure 5). On PET images acquired 24 h post injection, the liver, spleen, muscle and tumor 
display uptakes of 13 ± 1 %ID/g, 14 ± 2 %ID/g, 0.4 ± 0.1 %ID/g and 6 ± 2 %ID/g, respectively. 
Compatible results have recently been published for stealth liposomes,5,6,12 which demonstrate that the in 
vivo performance of liposomes loaded using the UAL method remains unchanged. The estimated blood 
circulation half-life of 9.7 h in mice is in agreement with earlier reports,11,12,23 and that no leakage of 64Cu-
DOTA from liposomes is observed in mice plasma (Figure S1). Together, these results substantiate the in 
vivo stability of liposomes loaded with 64Cu using the UAL method.  
 Liposomes loaded with 64Cu2+ using the UAL method was furthermore administered to a single 
canine cancer model. From PET/CT images, liposomes are found to accumulate in the spleen, liver and 
heart region 24 h post injection as expected. The accumulation in organs and tissues 24 h post injection 
has been determined via PET images, and SUVs of 3.8, 2.5 and 0.2 have been determined for the liver, 
spleen and muscle respectively. The blood clearance profile (Figure 6C) was determined upon 
administration of a single lipid dose (4.3 mg lipid/kg), which shows that more than 75% of the injected 
dose to be present in blood pool at the time of injection. The obtained circulation half-life of 24 h, 
moreover, agrees with recent findings by Susuki and co-workers, who, upon administration of pegylated 
liposomes (6.7 µmol lipid/kg / 5 mg lipid/kg), found an average half-life of 26 h in beagle dogs.32  
 With the increased recognition of the limitations in the use of SPECT for clinical liposome based 
imaging systems, improved radiolabeling methods are warranted and especially methods useful in PET 
imaging are needed. The unassisted 64Cu2+ loading method and the in vivo performance of the 64Cu-
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liposomal PET radiotracer presented here could eventually be useful in future clinical diagnostic and 
theranostic applications. 64Cu-loaded liposomes have several interesting future applications, and imaging 
studies in mice and canine cancer models could potentially provide more knowledge on how liposomal 
technology can be used in medical diagnostic and therapeutic applications. In clinical application, 64Cu-
liposomes could potentially be useful in liposomal drug development, in cancer diagnostic imaging and in 
various nano-theranostic applications such as in personalized medicine.1,2 
 
5. Conclusion  
We have successfully developed a highly efficient method for loading the PET radionuclide 64Cu2+ into 
liposomes. The new UAL method relies on unassisted transport of copper ions across the lipid bilayer of 
liposomes entrapping a chelator. We demonstrate highly efficient loading (>95%) for a range of lipid 
formulations, which suggests that copper forms a neutral specie capable of crossing the liposomal bilayer. 
We show that loading kinetics is highly temperature dependent contrary to the previously reported IAL 
loading method using 2HQ, and furthermore that stealth liposomes can be loaded (unassisted) with large 
quantities of copper. Once loaded, copper is shown to be present as a Cu-DOTA complex in oxidation 
state +2, pointing to the conclusion that Cu2+ ions cross the lipid bilayer and are trapped by the entrapped 
chelator.  
 64Cu-liposomes prepared by UAL show high tumor accumulation in mice and long-term blood 
circulation in a canine cancer model in agreement with previous biodistribution reports on the liposomal 
formulation. We observe that liposomes prepared by UAL or IAL have equivalent biodistribution and 
stability in vitro and in vivo.  
 This new Cu2+ unassisted loading method is simple, cost-efficient, robust, and highly 
thermodynamic stable with respect to radionuclide retention, contrary to surface chelation strategies that 
require tailored synthesis of lipid-chelator analogues and may suffer activity loss due to transmetallation 
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or migration of lipidated chelators in vivo. The loading stability of the UAL method is superior to other 
remote loading strategies that rely on pH or other chemical gradients, due to the high binding affinity of 
DOTA, which is a strong asset of the new method.   
 Contrary to what has been common knowledge and practice in the field of radionuclide liposome 
loading, we have developed an extremely simple and powerful tool for loading 64Cu2+ into liposomes 
without use of ionophores. The method provides 64Cu-liposomes with superior imaging properties due to 
the protected location of 64Cu2+ inside the liposomes, which prohibits 64Cu2+ exchange with the biological 
environment due to the protective barrier constituted by the liposome membrane. Thus, the 64Cu-
liposomes constitute a highly sensitive PET tracer useful in characterizing in vivo performance of 
liposome based nanomedicine with great potential in clinical cancer diagnostic imaging applications as 
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Figure S1. In vitro stability of 64Cu loaded HSPC:CHOL:DSPE-PEG2000 (56.5:38.2:5.3) liposomes in mice 
plasma. Size exclusion chromatograms are shown for liposomes that have been incubated for 18 h at 37°C 
in mice plasma (blue), and for 64Cu-DOTA as control (green).   
 	
 
